Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, MetroHealth Medical Center-Case Western Reserve University, Cleveland, OH.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, IL.
Am J Obstet Gynecol. 2016 Mar;214(3):389.e1-389.e12. doi: 10.1016/j.ajog.2015.09.095. Epub 2015 Oct 9.
Elective induction of labor (eIOL) prior to 39 weeks' gestation is discouraged because of presumed fetal benefits. However, few data exist on the maternal risks of expectant management. To date, no study has evaluated the maternal risk of developing a hypertensive disorder of pregnancy with expectant management of a low-risk gravid at term.
We sought to evaluate the development of hypertensive disorders in term low-risk expectantly managed patients.
This is a retrospective cross-sectional study from 19 US hospitals, from 2002 to 2008 (Safe Labor Consortium) including all nonanomalous, cephalic, singleton pregnancies at 37-41 weeks. Women with a history of hypertension, diabetes mellitus, cardiovascular disease, or planned cesarean delivery or from centers with incomplete hypertensive data were excluded. Women with eIOL in each week were compared with women managed expectantly until the next week of gestation or beyond. The primary outcome was the frequency of hypertensive complications.
Of 114,651 low-risk deliveries, 12,772 (11.1%) had eIOL. The cohort was 49.2% nulliparous, 51.1% white, and obese (mean body mass index 30.2 kg/m(2)). The risk of developing any hypertension in expectantly managed women was 4.1% after 37 weeks, 3.5% after 38 weeks, 3.2% after 39 weeks, and 2.6% after 40 weeks. Compared with eIOL, women with hypertensive disorders had significantly higher rates of cesarean delivery and maternal morbidities (intensive care unit admission or death, third- or fourth-degree lacerations, maternal infections, and bleeding complications) at each week of gestation and the composite neonatal morbidity at 38 and 39 weeks of gestation.
For women at low risk expectantly managed at term, there is a risk of developing hypertensive complications for each additional week of pregnancy, with associated increases in maternal and neonatal morbidities.
在 39 周之前择期引产(eIOL)不被鼓励,因为这对胎儿有益。然而,关于期待治疗的产妇风险的数据很少。迄今为止,尚无研究评估期待治疗足月低危孕妇时发生妊娠高血压疾病的风险。
我们旨在评估期待治疗足月低危患者中妊娠高血压的发生情况。
这是一项回顾性的横断面研究,共纳入了来自美国 19 家医院的患者,研究时间为 2002 年至 2008 年(安全分娩联合会),包括所有孕 37-41 周、非畸形、头位、单胎妊娠的孕妇。排除有高血压、糖尿病、心血管疾病病史或计划剖宫产、或来自高血压数据不完整中心的孕妇。在每一周进行 eIOL 的孕妇与期待治疗至下一周或更长时间的孕妇进行比较。主要结局是高血压并发症的发生频率。
在 114651 例低危分娩中,有 12772 例(11.1%)进行了 eIOL。该队列中 49.2%为初产妇,51.1%为白人,且肥胖(平均体重指数为 30.2kg/m2)。期待治疗的孕妇在 37 周后发生任何高血压的风险为 4.1%,38 周后为 3.5%,39 周后为 3.2%,40 周后为 2.6%。与 eIOL 相比,患有高血压疾病的孕妇在每个孕周的剖宫产率和产妇发病率(入住重症监护病房或死亡、三度或四度裂伤、产妇感染和出血并发症)以及 38 和 39 周的复合新生儿发病率均显著更高。
对于期待治疗的足月低危孕妇,每增加一周妊娠,就有发生妊娠高血压并发症的风险,随之而来的是母婴发病率的增加。